Tenax Therapeutics (TENX) Assets Average (2011 - 2026)
Tenax Therapeutics recorded quarterly Assets Average of $113.7 million in Q1 2026, up 9.84% quarter-over-quarter from $103.5 million in Q4 2025, and up 8.94% year-over-year from $104.4 million in Q1 2025.
Tenax Therapeutics' Assets Average history runs 14 years deep, the most recent figure standing at $113.7 million for Q1 2026.
- In Q1 2026, Assets Average rose 8.94% year-over-year to $113.7 million; the TTM figure through Mar 2026 stood at $113.7 million (up 8.94% YoY), while the FY2025 annual figure was $100.5 million, up 85.39% from the prior year.
- Assets Average came in at $113.7 million for Q1 2026 at Tenax Therapeutics, up from $103.5 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $113.7 million in Q1 2026 to a low of $4.1 million in Q4 2022.
- A 5-year average of $46.1 million and a median of $13.1 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average plunged 45.36% in 2022 and surged 768.98% in 2025, its largest moves.
- Tenax Therapeutics' Assets Average stood at $4.1 million in 2022, then surged by 189.47% to $11.8 million in 2023, then soared by 733.42% to $98.2 million in 2024, then rose by 5.38% to $103.5 million in 2025, then grew by 9.84% to $113.7 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $113.7 million, $103.5 million, and $104.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | 113.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 113.70 Mn |
| Dec 31, 2025 | 103.52 Mn |
| Sep 30, 2025 | 104.33 Mn |
| Jun 30, 2025 | 108.96 Mn |
| Mar 31, 2025 | 104.37 Mn |
| Dec 31, 2024 | 98.24 Mn |
| Sep 30, 2024 | 55.20 Mn |
| Jun 30, 2024 | 12.54 Mn |
| Mar 31, 2024 | 13.07 Mn |
| Dec 31, 2023 | 11.79 Mn |
| Sep 30, 2023 | 12.97 Mn |
| Jun 30, 2023 | 14.66 Mn |
| Mar 31, 2023 | 9.34 Mn |
| Dec 31, 2022 | 4.07 Mn |
| Sep 30, 2022 | 6.55 Mn |
| Jun 30, 2022 | 6.05 Mn |
| Mar 31, 2022 | 4.86 Mn |
| Dec 31, 2021 | 7.45 Mn |
| Sep 30, 2021 | 5.90 Mn |
| Jun 30, 2021 | 3.72 Mn |
| Mar 31, 2021 | 5.71 Mn |
| Dec 31, 2020 | 7.93 Mn |
| Sep 30, 2020 | 7.17 Mn |
| Jun 30, 2020 | 5.65 Mn |
| Mar 31, 2020 | 6.16 Mn |
| Dec 31, 2019 | 7.07 Mn |
| Sep 30, 2019 | 8.72 Mn |
| Jun 30, 2019 | 10.56 Mn |
| Mar 31, 2019 | 12.40 Mn |
| Dec 31, 2018 | 9.40 Mn |
| Sep 30, 2018 | 6.24 Mn |
| Jun 30, 2018 | 7.67 Mn |
| Mar 31, 2018 | 9.10 Mn |
| Dec 31, 2017 | 10.45 Mn |
| Sep 30, 2017 | 12.23 Mn |
| Jun 30, 2017 | 16.30 Mn |
| Mar 31, 2017 | 21.25 Mn |
| Dec 31, 2016 | 41.53 Mn |
| Sep 30, 2016 | 61.92 Mn |
| Apr 30, 2013 | 3.11 Mn |
| Jan 31, 2013 | 3.29 Mn |
| Oct 31, 2012 | 4.34 Mn |
| Jul 31, 2012 | 4.64 Mn |
| Apr 30, 2012 | 5.02 Mn |
| Jan 31, 2012 | 5.22 Mn |
| Oct 31, 2011 | 5.36 Mn |
| Jul 31, 2011 | 4.55 Mn |